These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

349 related articles for article (PubMed ID: 25307995)

  • 41. Treatment of Adults with Idiopathic Recurrent Pericarditis: Novel Use of Immunotherapy.
    Schwier NC; Hale GM; Davies ML
    Pharmacotherapy; 2017 Mar; 37(3):305-318. PubMed ID: 28079270
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Anakinra in idiopathic recurrent pericarditis refractory to immunosuppressive therapy; a preliminary experience in seven patients.
    Dagan A; Langevitz P; Shoenfeld Y; Shovman O
    Autoimmun Rev; 2019 Jun; 18(6):627-631. PubMed ID: 30959216
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Resolution of pericardial constriction with Anakinra in a patient with effusive-constrictive pericarditis secondary to rheumatoid arthritis.
    Schatz A; Trankle C; Yassen A; Chipko C; Rajab M; Abouzaki N; Abbate A
    Int J Cardiol; 2016 Nov; 223():215-216. PubMed ID: 27541656
    [No Abstract]   [Full Text] [Related]  

  • 44. Treatment with aspirin, NSAID, corticosteroids, and colchicine in acute and recurrent pericarditis.
    Imazio M; Adler Y
    Heart Fail Rev; 2013 May; 18(3):355-60. PubMed ID: 22661042
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Usefulness of Interleukin-1 Receptor Antagonists in Patients With Recurrent Pericarditis.
    Khayata M; Shah NP; Verma BR; Giugni AS; Alkharabsheh S; Asher CR; Imazio M; Klein AL
    Am J Cardiol; 2020 Jul; 127():184-190. PubMed ID: 32416963
    [TBL] [Abstract][Full Text] [Related]  

  • 46. New Developments in the Management of Recurrent Pericarditis.
    Imazio M; Mardigyan V; Andreis A; Franchin L; De Biasio M; Collini V
    Can J Cardiol; 2023 Aug; 39(8):1103-1110. PubMed ID: 37075863
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Recurrent pericarditis after chemotherapy for acute myeloid leukemia: a case report and a modern approach to chemotherapy-induced pericarditis.
    Lee GY; Ahn KT; Jung CW; Chang SA
    Cardiology; 2011; 120(3):130-4. PubMed ID: 22179126
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Advances in medical therapy for pericardial diseases.
    Galluzzo A; Imazio M
    Expert Rev Cardiovasc Ther; 2018 Sep; 16(9):635-643. PubMed ID: 30103638
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Recurrent Pericarditis.
    Imazio M; Gribaudo E; Gaita F
    Prog Cardiovasc Dis; 2017; 59(4):360-368. PubMed ID: 27725173
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Resistant or recurrent acute pericarditis: a new therapeutic opportunity?
    Massardier C; Dauphin C; Eschalier R; Lusson JR; Soubrier M
    Int J Cardiol; 2014 Dec; 177(2):e75-7. PubMed ID: 25449496
    [No Abstract]   [Full Text] [Related]  

  • 51. [Recurrent pericarditis: New treatment].
    Cacoub P
    Rev Med Interne; 2020 Apr; 41(4):223-225. PubMed ID: 31874776
    [No Abstract]   [Full Text] [Related]  

  • 52. [Recurrent acute idiopathic pericarditis: rheumatologic therapy, autoantibodies and long term outcome].
    Brambilla G; Brucato A; Adler Y; Bosetti M; Coppini P; Caforio A; Spodick D; Canesi B
    Reumatismo; 2007; 59(1):25-31. PubMed ID: 17435839
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Usefulness of Novel Immunotherapeutic Strategies for Idiopathic Recurrent Pericarditis.
    Lotan D; Wasserstrum Y; Fardman A; Kogan M; Adler Y
    Am J Cardiol; 2016 Mar; 117(5):861-6. PubMed ID: 26742476
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A systematic review and meta-analysis of randomized controlled trials evaluating pharmacologic therapies for acute and recurrent pericarditis.
    Melendo-Viu M; Marchán-Lopez Á; Guarch CJ; Roubín SR; Abu-Assi E; Meneses RT; Ynsaurriaga FA; Hernandez AV; Bueno H
    Trends Cardiovasc Med; 2023 Jul; 33(5):319-326. PubMed ID: 35131416
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A novel therapy for an unusual problem: IL-1 receptor antagonist for recurrent post-transplant pericarditis.
    Parizo JT; Moayedi Y; Nieman K; Town K; Teuteberg JJ; Khush KK
    Clin Transplant; 2019 Oct; 33(10):e13699. PubMed ID: 31437316
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Intravenous immunoglobulin therapy for refractory recurrent pericarditis.
    del Fresno MR; Peralta JE; Granados MÁ; Enríquez E; Domínguez-Pinilla N; de Inocencio J
    Pediatrics; 2014 Nov; 134(5):e1441-6. PubMed ID: 25287461
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Pharmacotherapeutic considerations for using colchicine to treat idiopathic pericarditis in the USA.
    Schwier NC
    Am J Cardiovasc Drugs; 2015 Oct; 15(5):295-306. PubMed ID: 26243656
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Recurrent pericarditis: infectious or autoimmune?
    Brucato A; Maestroni S; Cumetti D; Thiella G; Alari G; Brambilla G; Imazio M; Doria A; Palmieri G; Adler Y
    Autoimmun Rev; 2008 Oct; 8(1):44-7. PubMed ID: 18708165
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Pericarditis in an athlete. How long must he abstain from sports?].
    Herdeg C
    MMW Fortschr Med; 2011 Dec; 153(49-50):24. PubMed ID: 22308587
    [No Abstract]   [Full Text] [Related]  

  • 60. CORP (COlchicine for Recurrent Pericarditis) and CORP-2 trials--two randomized placebo-controlled trials evaluating the clinical benefits of colchicine as adjunct to conventional therapy in the treatment and prevention of recurrent pericarditis: study design and rationale.
    Imazio M; Cecchi E; Ierna S; Trinchero R;
    J Cardiovasc Med (Hagerstown); 2007 Oct; 8(10):830-4. PubMed ID: 17885522
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.